Advertisement

Evaluation and Management of Chronic Pain

  • Peter S. StaatsEmail author
  • Sean Li
Chapter

Abstract

Chronic pain is one of the leading health-care crises in America today, affecting more patients than cancer and heart disease combined. In response to uncontrolled pain, the use of prescription opioid analgesics has soared, resulting in a second problem, one of addiction. In order to optimally treat patients with pain, while minimizing the risks of abuse diversion or addiction, it is important to establish an accurate diagnosis and design the most appropriate treatment plan. Moreover there are multiple strategies that are known to be effective in pain. A thorough understanding of the options available to physicians is likely to improve pain control and minimize risks.

Keywords

Chronic pain Opioids Interventional pain Neuromodulation CRPS Spinal cord stimulation Vertebroplasty 

References

  1. 1.
    Merskey H, Bodguk N. Classification of chronic pain: descriptions of chronic pain syndromes and definition of pain terms. 2nd ed. IASP Press. Seattle. 1994.Google Scholar
  2. 2.
    Staats PS, Hekmat H, Staats AW. Psychological behaviorism theory of pain: a basis for unity. Pain Forum. 1996;5:194–207.CrossRefGoogle Scholar
  3. 3.
    Staats PS, Staats A, Hekmat H. The additive impact of anxiety and a placebo on pain. Pain Med. 2001;2:267–79.CrossRefPubMedGoogle Scholar
  4. 4.
    Thrush D. Congenital insensitivity to pain. Brain. 1973;96:369–86.CrossRefPubMedGoogle Scholar
  5. 5.
    Ashburn MA, Staats PS. The management of chronic pain. Lancet. 1999;353:1865–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Staats PS, Wallace MS. Pain medicine: just the facts. 2nd ed. McGraw Hill; New York. 2015.Google Scholar
  7. 7.
    Diwan S, Staats PS. The Diwan Staats atlas pain medicine procedures. McGraw Hill; New York. 2015.Google Scholar
  8. 8.
    Gupta R, Staats PS. Diagnostic tools in the management of pain. In: Expert pain management. Springhouse Corporation; North Wales. 1997.Google Scholar
  9. 9.
    Wong DL, Hackenberry-Eaton M, Wilson D, Winkelstein ML, Schwartz P. Wong’s essentials of pediatric nursing. 6th ed. St. Louis; Missouri. 2001, p. 1301.Google Scholar
  10. 10.
    McCaffery M, Pasero C. Pain: clinical manual. St. Louis; Missouri. 1999, p. 16.Google Scholar
  11. 11.
    Guarino A, Staats PS. Diagnostic neural blockade in the management of pain. Pain Digest. 1997;7:194–9.Google Scholar
  12. 12.
    Boswell MV, Singh V, Staats PS, Hirsch JA. Accuracy of precision diagnostic blocks in the diagnosis of chronic spinal pain of facet or zygapophysial joint origin. Pain Physician. 2003;6:449–56.PubMedGoogle Scholar
  13. 13.
    Benzon HT, et al. Essentials of pain medicine. 3rd ed. Elsevier, Philadelphia. 2011Google Scholar
  14. 14.
    Krames ES. Intraspinal opioid therapy for nonmalignant pain: current practices and clinical guidelines. J Pain Symptom Manage. 1996;11:333–52.CrossRefPubMedGoogle Scholar
  15. 15.
    Stamatos JM, et al. Live your life pain free. Based on the interventional pain management experience of Dr. John Stamatos. McKinney, TX. 2005.Google Scholar
  16. 16.
    Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2—guidance. Pain Physician. 2012;15(3 Suppl):S67–116.Google Scholar
  17. 17.
    Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic non-cancer pain. J Pain. 2009;10:113.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    World Health Organization. Cancer pain relief. Geneva: World Health Organization; 1990.Google Scholar
  19. 19.
    Furlan AD, Sandoval JA, Mailis-Gagnon A, et al. Opioids for chronic non-cancer pain: a meta-analysis of effectiveness and side effects. Can Med Assoc J. 2006;174:1589–94.CrossRefGoogle Scholar
  20. 20.
    Chou R, Huffman L. Use of chronic opioid therapy in chronic non-cancer pain: a systematic review. American Pain Society; 2009.Google Scholar
  21. 21.
    Manchikanti L, Koyyalagunta L, Datta S, et al. A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain. Pain Physician. 2011;14:91–121.PubMedGoogle Scholar
  22. 22.
    Trescot AM, Helm S, Benyamin R, et al. Opioids in the management of chronic non-cancer pain: an update of the American Society of Interventional Pain Physicians (ASIPP) guidelines. Pain Physician. 2008;11:S5–62.PubMedGoogle Scholar
  23. 23.
    MLA citation– Medicare Payment Advisory Commission (U.S.). Report to the Congress: Paying for Outpatient Services In Cancer Hospitals. Washington, DC: MedPac. 2001.Google Scholar
  24. 24.
    Staats PS. The effect of pain on survival. In: Interventional pain management Anesthesiology Clinics of North America. Guest Ed Staats PS. Philadelphia: Lippincott, Williams and Wilkins, 2003;Google Scholar
  25. 25.
    Staats PS. Pain, depression and survival. Am Fam Physician. 1999;60:42–4.PubMedGoogle Scholar
  26. 26.
    Manchikanti L, Staats PS, Nampiaparampil DE. What is the role of epidural injections in the treatment of lumbar discogenic pain: a system 4/2015. Korean J Pain. 2015;28:75–87.Google Scholar
  27. 27.
    Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007;6:326–31.CrossRefGoogle Scholar
  28. 28.
    Anselmetti CG, et al. Percutaneous vertebroplasty in osteoporotic patients: an institutional experience of 1,634 patients with long-term follow-up. J Vasc Intervent Radiol. 2011;22:1714–20.CrossRefGoogle Scholar
  29. 29.
    Benyamin R, Staats PS, Davis K, et al. Accepted for publication. Midas Encore, Pain Physician 2015.Google Scholar
  30. 30.
    Li S, Staats PS. Permanent implant (intrathecal drug delivery). The atlas of interventional pain care. New York: McGraw-Hill; 2015.Google Scholar
  31. 31.
    North RB, Kidd DH, Shipley J. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analysis based on a randomized controlled clinical trial. Neurosurgery. 2007;61:361.CrossRefPubMedGoogle Scholar
  32. 32.
    Kumar K, et al. The effects of spinal cord stimulation in neuropathic pain are sustained: a 24 month follow up of the prospective randomized controlled multicenter trial of effectiveness of spinal cord stimulation. Neurosurgery. 2008;63:762–70.CrossRefPubMedGoogle Scholar
  33. 33.
    Buyten V, et al. High-frequency spinal cord stimulation for the treatment of chronic back pain patients: results of a prospective multicenter European Clinical Study. Neuromodulation. 2013;16:59–66.CrossRefPubMedGoogle Scholar
  34. 34.
    DeRidder D, et al. Burst stimulation for back and limb pain. World Neurosurg. 2013;80:642–9.CrossRefGoogle Scholar
  35. 35.
    Kramer J, Draper CE, Deer TR, et al. Dorsal root ganglion stimulation: anatomy physiology and potential for therapeautic targeting in chronic pain. In: Diwan S, editor. The Diwan Staats Atlas of pain medicine procedures. McGraw Hill; New York. 2015. p. 626–31.Google Scholar
  36. 36.
    Deer TR, Mekhail N, Petersen E, Krames E, Staats P, Pope J, Saweris Y, Lad SP, Diwan S, Falowski S, Feler C, Slavin K, Narouze S, Merabet L, Buvanendran A, Fregni F, Wellington J, Levy RM. The appropriate use of neurostimulation: stimulation of the intracranial and extracranial space and head for chronic pain. Neuromodulation. 2014;17:551–70.CrossRefPubMedGoogle Scholar
  37. 37.
    Pope J, Deer T, McRoberts WP. The Burden of being positioned as a salvage therapy. Pain Med. 2015;16(10):2036–8.CrossRefPubMedGoogle Scholar
  38. 38.
    Smith TJ, Coyne PJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Català E, Bryce DA, Cousins M, Pool GE. An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM). Ann Oncol. 2005;16:825–33.CrossRefPubMedGoogle Scholar
  39. 39.
    Kumar K, et al. Treatment of chronic pain by using a intrathecal drug delivery compared to conventional treatments. A cost effectiveness analysis. J Neurosurg. 2002;97:803–10.CrossRefPubMedGoogle Scholar
  40. 40.
    Staats PS, et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled clinical trial. JAMA. 2004;1:291.Google Scholar
  41. 41.
    Wallace MS, Charapata S, Fisher R, Staats PS, et al. The Ziconotide Nonmalignant Pain Study Group. Intrathecal Ziconotide in the treatment of chronic nonmalignant pain: a randomized double blind placebo controlled trial. Neuromodulation. 2006;9:75–86.Google Scholar
  42. 42.
    Prager J, Deer T, Levy R, et al. Best practices for intrathecal drug delivery for pain. Neuromodulation. 2014;17(4):354–72.Google Scholar
  43. 43.
    Deer TR, Prager J, Levy R, Rathmell J, Buchser E, Burton A, Caraway D, Cousins M, De Andrés J, Diwan S, Erdek M, Grigsby E, Huntoon M, Jacobs MS, Kim P, Kumar K, Leong M, Liem L, McDowell II GC, Panchal S, Rauck R, Saulino M, Sitzman BT, Staats P, Stanton-Hicks M, Stearns L, Wallace M, Willis KD, Witt W, Yaksh T, Mekhail N. Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by Intrathecal (Intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodul Technol Neural Interface. 2012;15:436–66.CrossRefGoogle Scholar
  44. 44.
    WHO’s pain ladder for adults. World Health Organization Web site. http://www.who.int/cancer/palliative/painladder/en/#. Accessed May 5 2013.

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Interventional Pain PhysicianPremier Pain CentersShrewsburyUSA

Personalised recommendations